Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 4/20 | 0.40 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.40 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.40 |
| ▸ | MAPT | P10636 | 1/20 | 0.36 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.36 |
| ▸ | ACE | P12821 | 1/20 | 0.35 |
| ▸ | FAAH | O00519 | 3/20 | 0.33 |
| ▸ | BBOX1 | O75936 | 2/20 | 0.32 |
| ▸ | LMNA | P02545 | 2/20 | 0.32 |
| ▸ | SLC22A6 | Q4U2R8 | 1/20 | 0.32 |
| ▸ | TP53 | P04637 | 1/20 | 0.30 |
| ▸ | FOLH1 | Q04609 | 1/20 | 0.30 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.30 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6011836 | 0.94 | MAPT (0.39) | TSHRTDP1ALDH1A1MAPTKMT2A | |
| SCHEMBL6011904 | 0.90 | MAPT (0.40) | TSHRTDP1ALDH1A1MAPTKMT2A | |
| SCHEMBL28696059 | 0.87 | MAPT (0.44) | TSHRTDP1ALDH1A1MAPTKMT2A | |
| SCHEMBL28696440 | 0.87 | MAPT (0.44) | TSHRTDP1ALDH1A1MAPTKMT2A | |
| SCHEMBL28690025 | 0.87 | MAPT (0.44) | TSHRTDP1ALDH1A1MAPTKMT2A | |
| SCHEMBL28684308 | 0.87 | MAPT (0.44) | TSHRTDP1ALDH1A1MAPTKMT2A | |
| SCHEMBL10696543 | 0.87 | MAPT (0.44) | TSHRTDP1ALDH1A1MAPTKMT2A | |
| SCHEMBL2418248 | 0.87 | — | — | |
| SCHEMBL14842097 | 0.86 | — | — | |
| SCHEMBL10972287 | 0.86 | ALDH1A1 (0.52) | TSHRTDP1ALDH1A1MAPTKMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 108 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119875052-A | Ion polymer based on flexible main chain, anion exchange membrane and preparation method thereof | 武汉轻工大学 | 2025-04-25 | — | — | CN | claimed |
| CN-115724728-B | Synthesis process of 1, 7-dichloro-4-heptanone | 常州沃腾化工科技有限公司 | 2024-06-21 | — | — | CN | claimed |
| CN-116514818-A | Preparation method of piracy carnitinib intermediate | 诚弘制药(威海)有限责任公司 | 2023-08-01 | — | — | CN | claimed |
| CN-115724728-A | Synthesis process of 1, 7-dichloro-4-heptanone | 常州沃腾化工科技有限公司 | 2023-03-03 | — | — | CN | claimed |
| CN-114058173-A | Process and composition for producing flexible polyurethane foams | 赢创运营有限公司 | 2022-02-18 | — | — | CN | claimed |
| US-4059610-A | Process for preparing isocyanic acid derivatives | KAO SOAP CO., LTD. (JA) | 1977-11-22 | — | — | US | claimed |
| CN-119875052-B | Ion polymer based on flexible main chain, anion exchange membrane and preparation method thereof | 武汉轻工大学 | 2025-06-27 | — | — | CN | disclosed |
| WO-2025137516-A1 | FLUORINATED MONOMERS, ANION EXCHANGE POLYMERS AND METHODS OF MAKING THE SAME | THE CHEMOURS COMPANY FC, LLC (US) | 2025-06-26 | — | — | WO | disclosed |
| CN-119875052-A | Ion polymer based on flexible main chain, anion exchange membrane and preparation method thereof | 武汉轻工大学 | 2025-04-25 | — | — | CN | disclosed |
| CN-119875052-A | Ion polymer based on flexible main chain, anion exchange membrane and preparation method thereof | 武汉轻工大学 | 2025-04-25 | — | — | CN | disclosed |
| US-20250129096-A1 | ANNULATED 2-AMINO-3-CYANO THIOPHENES AND DERIVATIVES FOR THE TREATMENT OF CANCER | BOEHRINGER INGELHEIM INTL GMBH CORP (DE) | 2025-04-24 | — | — | US | disclosed |
| EP-4441054-A1 | ANNULATED 2-AMINO-3-CYANO THIOPHENES AND DERIVATIVES FOR THE TREATMENT OF CANCER | Boehringer Ingelheim International GmbH (DE) | 2024-10-09 | — | — | EP | disclosed |
| CN-115724728-B | Synthesis process of 1, 7-dichloro-4-heptanone | 常州沃腾化工科技有限公司 | 2024-06-21 | — | — | CN | disclosed |
| EP-0345711-A2 | Process for the preparation of pyrrolizine derivatives | SANWA KAGAKU KENKYUSHO CO., LTD. (JP) | 1989-12-13 | — | — | EP | disclosed |
| EP-0345712-A1 | Pyrrolizine derivate and its manufacture | SANWA KAGAKU KENKYUSHO CO., LTD. (JP) | 1989-12-13 | — | — | EP | disclosed |
| US-4141910-A | PLASTICIZERS, OXIDIZERS | ROCKWELL INTERNATIONAL CORPORATION (US) | 1979-02-27 | — | — | US | disclosed |
| US-4125552-A | FROM A HALIDE, AMMONIA, HYDROCARBYLAMINE, HYDROGEN SULFIDE AND SULFUR | DOW CORNING CORPORATION (US) | 1978-11-14 | — | — | US | disclosed |
| US-4082790-A | ORGANIC HALIDE, HYDROGEN SULFIDE, AMMONIA OR AMINE, POLAR SOLVENT | DOW CORNING CORPORATION (US) | 1978-04-04 | — | — | US | disclosed |
| US-4059610-A | Process for preparing isocyanic acid derivatives | KAO SOAP CO., LTD. (JA) | 1977-11-22 | — | — | US | disclosed |
| US-4009208-A | N,N'-HEPTAMETHYLENEBIS(4-METHOXYBENZAMIDE) | STERLING DRUG INC. (US) | 1977-02-22 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250129096-A1 | ANNULATED 2-AMINO-3-CYANO THIOPHENES AND DERIVATIVES FOR THE TREATMENT OF CANCER | KRAS, NRAS, TP53 | TSHR 1062/4885TDP1 1857/4885ALDH1A1 2310/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.